{"id":58844,"date":"2024-02-28T05:30:40","date_gmt":"2024-02-28T05:30:40","guid":{"rendered":"https:\/\/medsname.com\/pexep-cr\/"},"modified":"2026-04-30T10:24:07","modified_gmt":"2026-04-30T10:24:07","slug":"pexep-cr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/pexep-cr\/","title":{"rendered":"Pexep CR"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Snel antwoord<\/h3>\n

Pexep CR (Paroxetine HCl 12.5 \/ 25 \/ 37.5 mg) is a selective serotonin reuptake inhibitor used for depression, anxiety, and related disorders. Strong serotonin reuptake blockade \u2014 effective but with the worst discontinuation profile of any SSRI; taper carefully.<\/p>\n<\/div>\n

\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Pexep CR at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy<\/a> \u2014 20 werkdagen levertermijn of wij sturen kosteloos opnieuw \u2014 en komt in aanmerking voor ons klantenloyaliteitsprogramma<\/a>. Wereldwijde verzending is beschikbaar naar de meeste bestemmingen.<\/p>\n

How Pexep CR works<\/h2>\n

Pexep CR<\/strong> is a Paroxetine HCl-containing SSRI tablet supplied by Sun Pharma. Available strengths: 12.5 \/ 25 \/ 37.5 mg<\/strong>. Take with or without food, at the same time each day for steady-state plasma levels.<\/p>\n

SSRIs block the reuptake of serotonin (5-HT) at the presynaptic serotonin transporter (SERT), increasing synaptic serotonin availability. The therapeutic effect lags transporter blockade by 2\u20136 weeks \u2014 the delay reflects downstream adaptations in 5-HT autoreceptor sensitivity, BDNF expression, and hippocampal neurogenesis, not direct receptor effects. Patients who feel “nothing” at 2 weeks should not stop early; assess response at 4\u20136 weeks of an adequate dose.<\/p>\n

Paroxetine CR was developed primarily to reduce morning nausea<\/strong> and the early “wakeful” sedation that hit IR users. The 25 mg CR dose is approximately equivalent to 20 mg IR. Take whole \u2014 do not crush, split, or chew the controlled-release tablet (this defeats the formulation and produces an IR dose-dump).<\/p>\n

Indicaties en dosering<\/h2>\n\n\n\n\n\n\n\n\n\n
Indicatie<\/th>\nStartdosering<\/th>\nStreefdosering<\/th>\nMaximaal<\/th>\n<\/tr>\n<\/thead>\n
Depressie<\/td>\n25 mg OD<\/td>\n25\u201362.5 mg OD<\/td>\n62.5 mg<\/td>\n<\/tr>\n
Paniekstoornis<\/td>\n12.5 mg OD \u00d7 1 wk<\/td>\n25\u201375 mg OD<\/td>\n\u26a1 Snelle vraag \u2014 Wat is Ecosprin?<\/td>\n<\/tr>\n
Social anxiety<\/td>\n12.5 mg OD<\/td>\n12.5\u201337.5 mg OD<\/td>\n37.5 mg<\/td>\n<\/tr>\n
PMDD (continuous or luteal)<\/td>\n12.5 mg OD<\/td>\n12.5\u201325 mg OD<\/td>\n25 mg<\/td>\n<\/tr>\n
Older adults \/ hepatic<\/td>\n12.5 mg OD<\/td>\n12.5\u201350 mg OD<\/td>\n50 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Belangrijke veiligheidsoverwegingen<\/h2>\n
\nSame withdrawal as IR \u2014 taper carefully<\/strong><\/p>\n

The controlled-release formulation does not change the elimination half-life or the active moiety in plasma \u2014 it only flattens the absorption peak. Withdrawal on missed doses or abrupt cessation is the same as immediate-release paroxetine. Always taper over at least 4 weeks.<\/p>\n<\/div>\n

\nZwarte waarschuwing voor su\u00efcidaliteit (onder 25)<\/strong><\/p>\n

All SSRIs carry an FDA black-box warning for increased suicidal ideation in patients under 25, particularly in the first 4 weeks and at dose changes. This does niet<\/em> mean SSRIs are net-harmful in young people \u2014 meta-analyses show net benefit \u2014 but it does mean close clinical monitoring during initiation and titration in adolescents and young adults.<\/p>\n<\/div>\n

\nSerotonin syndrome<\/strong><\/p>\n

Combining Pexep CR with other serotonergic agents can cause serotonin syndrome (tremor, hyperreflexia, clonus, hyperthermia, agitation). Avoid concurrent: MAOIs (14-day washout each direction; fluoxetine needs 5 weeks), tramadol, pethidine, dextromethorphan, linezolid, methylene blue, St John’s wort, MDMA. Triptan + SSRI is generally tolerated for migraine \u2014 the absolute risk is low.<\/p>\n<\/div>\n

Veelvoorkomende bijwerkingen<\/h2>\n